Epidermal growth factor receptor (EGFR) mutations, frequently observed in inverted papilloma (IP) and associated with low risk of SCC transformation [7], could represent a potential target in the prognosis and treatment of this cancer type [10]. Here, EGFR is linked to incontinentia pigmenti.